A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 2,249,674 shares of PFE stock, worth $63 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,249,674
Previous 2,073,695 8.49%
Holding current value
$63 Million
Previous $59.7 Million 4.57%
% of portfolio
0.09%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $4.56 Million - $5.23 Million
175,979 Added 8.49%
2,249,674 $62.4 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $13.7 Million - $17.7 Million
-522,816 Reduced 20.14%
2,073,695 $59.7 Million
Q3 2023

Oct 24, 2023

BUY
$32.09 - $37.51 $802,506 - $938,050
25,008 Added 0.97%
2,596,511 $86.1 Million
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $1.81 Million - $2.09 Million
50,012 Added 1.98%
2,571,503 $94.3 Million
Q1 2023

Apr 14, 2023

SELL
$39.39 - $51.28 $1.7 Million - $2.21 Million
-43,123 Reduced 1.68%
2,521,491 $103 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $6.31 Million - $8.23 Million
-151,045 Reduced 5.56%
2,564,614 $131 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $27,525 - $33,601
629 Added 0.02%
2,715,659 $119 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $2.55 Million - $3.02 Million
-54,742 Reduced 1.98%
2,715,030 $142 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $5.06 Million - $6.28 Million
-110,696 Reduced 3.84%
2,769,772 $143 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $3.1 Million - $4.6 Million
75,021 Added 2.67%
2,880,468 $170 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $2.33 Million - $3 Million
-59,427 Reduced 2.07%
2,805,447 $121 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $259,952 - $294,482
7,239 Added 0.25%
2,864,874 $112 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $6.95 Million - $7.84 Million
207,500 Added 7.83%
2,857,635 $104 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $5.96 Million - $7.58 Million
178,076 Added 7.2%
2,650,135 $97.6 Million
Q3 2020

Nov 04, 2020

SELL
$31.75 - $37.25 $4.61 Million - $5.41 Million
-145,158 Reduced 5.55%
2,472,059 $90.7 Million
Q2 2020

Jul 17, 2020

SELL
$30.12 - $36.54 $66.8 Million - $81 Million
-2,217,041 Reduced 45.86%
2,617,217 $85.6 Million
Q1 2020

Apr 21, 2020

BUY
$27.03 - $38.62 $8.67 Million - $12.4 Million
320,781 Added 7.11%
4,834,258 $158 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $10 Million - $11.3 Million
303,768 Added 7.22%
4,513,477 $177 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $5.57 Million - $7.23 Million
171,531 Added 4.25%
4,209,709 $151 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $8.75 Million - $9.82 Million
236,612 Added 6.22%
4,038,178 $175 Million
Q1 2019

May 06, 2019

BUY
$37.5 - $41.2 $11 Million - $12.1 Million
293,426 Added 8.36%
3,801,566 $161 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $8.67 Million - $9.89 Million
225,451 Added 6.87%
3,508,140 $153 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $6.46 Million - $7.84 Million
187,398 Added 6.05%
3,282,689 $145 Million
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $8.1 Million - $8.63 Million
245,467 Added 8.61%
3,095,291 $112 Million
Q1 2018

Apr 16, 2018

BUY
$31.91 - $37.02 $7.71 Million - $8.94 Million
241,584 Added 9.26%
2,849,824 $101 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $8.41 Million - $8.93 Million
252,948 Added 10.74%
2,608,240 $94.5 Million
Q3 2017

Oct 26, 2017

BUY
$31.0 - $34.15 $3.36 Million - $3.7 Million
108,291 Added 4.82%
2,355,292 $84.1 Million
Q2 2017

Aug 15, 2017

BUY
N/A
2,247,001
2,247,001 $75.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.